Clinical Trial Update: A Study of JNJ-75276617 in Combination With Conventional Chemotherapy for Pediatric and Young Adult Participants With Relapsed/Refractory Acute Leukemias [Phase 1]

View source ↗

Summary

A Phase 1 trial of JNJ-75276617 in combination with conventional chemotherapy for pediatric and young adult patients with relapsed/refractory acute leukemias ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Leukemia
• Leukemia of Ambiguous Lineage

Drugs mentioned

• JNJ-75276617

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Acute Leukemias, Acute Myeloid Leukemia | Phase 1 | Status: WITHDRAWN